BIOMAT Database Logo BIOMAT Database Logo

The effect of pyridinolcarbamate on the skin microcirculation in patients with severe skin necroses. A double-blind trial study. 1976

B Fagrell

UI MeSH Term Description Entries
D008297 Male Males
D008833 Microcirculation The circulation of the BLOOD through the MICROVASCULAR NETWORK. Microvascular Blood Flow,Microvascular Circulation,Blood Flow, Microvascular,Circulation, Microvascular,Flow, Microvascular Blood,Microvascular Blood Flows,Microvascular Circulations
D009336 Necrosis The death of cells in an organ or tissue due to disease, injury or failure of the blood supply.
D011727 Pyridinolcarbamate A drug that has been given by mouth in the treatment of atherosclerosis and other vascular disorders, hyperlipidemias, and thrombo-embolic disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1408) Pyricarbate,2,6-Pyridinedimethanol-bis-(N-methylcarbamate),Anginin,Angioxine,Colesterinex,Duaxol,Duvaline,Gasparol,Lisator,Movecil,P-23,Parmidine,Prodectin,Sospitan,P 23,P23
D002219 Carbamates Derivatives of carbamic acid, H2NC( Carbamate,Aminoformic Acids,Carbamic Acids,Acids, Aminoformic,Acids, Carbamic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.
D012871 Skin Diseases Diseases involving the DERMIS or EPIDERMIS. Dermatoses,Skin and Subcutaneous Tissue Disorders,Dermatosis,Skin Disease

Related Publications

B Fagrell
[A double blind crossover trial in pyridinolcarbamate treatment of atherosclerosis obliterans].
April 1969, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
B Fagrell
Pyridinolcarbamate in the treatment of ischemic heart diseases. A double blind study.
January 1972, Japanese heart journal,
B Fagrell
[The effect of pyridinolcarbamate (parmidine) on the microcirculation and immunity of patients with stable angina].
January 1993, Kardiologiia,
B Fagrell
Double-blind crossoer clinical trial of pyridinolcarbamate in peripheral arterial disease (arteriosclerosis obliterans).
February 1973, British heart journal,
B Fagrell
Effect of Ioxaglate on the cutaneous microcirculation in patients with coronary artery disease: Randomized, double blind, placebo-controlled study.
January 2016, Clinical hemorheology and microcirculation,
B Fagrell
Electrocardiographic and hematological changes by exercise test in coronary patients and pyridinolcarbamate pretreatment. A double-blind crossover trial.
May 1970, American heart journal,
B Fagrell
Effect of intravenous immunoglobulin on steroid consumption in patients with severe asthma: a double-blind, placebo-controlled, randomized trial.
May 1999, The Journal of allergy and clinical immunology,
B Fagrell
The effect of phenylbutazone on patients with acute lumbago-sciatica. A double blind trial.
May 1980, Journal of the Oslo city hospitals,
B Fagrell
Effect of ibuprofen in patients with severe sepsis: a randomized, double-blind, multicenter study. The Ibuprofen Study Group.
November 1991, Critical care medicine,
B Fagrell
A randomised double-blind placebo-controlled add-on trial of lamotrigine in patients with severe epilepsy.
August 1990, Epilepsy research,
Copied contents to your clipboard!